B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Lapatinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Lapatinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

canertinib
5 shared targets
dacomitinib
5 shared targets
ac
4 shared targets
maleimide
7 shared targets
varlitinib
4 shared targets
aee
7 shared targets
apitolisib
6 shared targets
brivanib
8 shared targets
icotinib
4 shared targets
osimertinib
4 shared targets
Loading evidence profile...

This evidence profile for Lapatinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.